M&A Deal Summary

Axcan Pharmaceuticals Acquires Mpex Pharmaceuticals

On April 14, 2011, Axcan Pharmaceuticals acquired life science company Mpex Pharmaceuticals from Adams Street Partners

Acquisition Highlights
  • This is Axcan Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Axcan Pharmaceuticals’ 1st transaction in the United States.
  • This is Axcan Pharmaceuticals’ 1st transaction in California.

M&A Deal Summary

Date 2011-04-14
Target Mpex Pharmaceuticals
Sector Life Science
Buyer(s) Axcan Pharmaceuticals
Sellers(s) Adams Street Partners
Deal Type Add-on Acquisition

Target

Mpex Pharmaceuticals

San Diego, California, United States
Mpex Pharmaceuticals is a biopharmaceutical company developing new therapies to combat the growing issue of antibiotic resistance, with a particular focus on gram-negative organisms.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Axcan Pharmaceuticals

Mont-Saint-Hilaire, Quebec, Canada

Category Company
Sector Life Science
DESCRIPTION

Specialty pharmaceutical company focused on development and commercialization of drugs for diseases of the digestive system.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2011 M&A 1 of 1

Seller(S) 1

SELLER

Adams Street Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor


Category Asset Manager
Founded 1972
PE ASSETS 60.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Adams Street Partners is a diversified, global investment firm that targets direct, fund of funds, and secondary investments. Adams' direct investing group covers co-investments in buyout transactions, as well as growth equity and venture capital commitments. The direct buyout and growth equity team looks to commit $5 to $30 million per transaction. For venture related investments, commitments of $5 to $20 million are provided to companies in the technology, life sciences and technology enabled services sectors. Typically, target companies have received prior financing from early stage venture firms and are seeking additional capital to fund product development and commercialization. Adams Street Partners was formed in 1972 and is based in Chicago, Illinois.


DEAL STATS #
Overall 33 of 101
Sector: Life Science M&A 5 of 15
Type: Add-on Acquisition M&A Deals 17 of 54
State: California M&A 14 of 45
Country: United States M&A 32 of 93
Year: 2011 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-15 ReVascular Therapeutics

Sunnyvale, California, United States

Revascular Therapeutics, Inc. operates as an arterial occlusion treatment company. It develops percutaneous medical devices to reopen occluded vessels. The company develops technology for the intravascular treatment of complex lesions and total occlusions. Revascular Therapeutics, Inc. was incorporated in 1999 and is headquartered in Sunnyvale, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-29 Spiceworks

Austin, Texas, United States

Spiceworks is a provider of network management and social software for SMB IT professionals. Spiceworks is based in Austin, Texas.

Buy -